CCL2 and neoplasm: OV-mediated ICD triggers the release of IL-6, IL-8, IFN-β, IP-10 (CXCL10), MCP-1 (CCL2) and KC (CXCL1) from cancer cells to recruit different immune cells and initiate an anti-tumor response [54,55,76,77].